Get the Stockscreener App
0.1185
5.50%
-0.0069
After Hours:
.12
0.0015
+1.27%
Conduit Pharmaceuticals Inc Stock (CDT) Forecast
The Conduit Pharmaceuticals Inc (CDT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.2128, representing a +923.44% increase from the current price of $0.1185. The highest analyst price target is $1.8527, and the lowest is $0.5729.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CDT Price Target
Average 3.4989
(+2,853% Upside)
Is Conduit Pharmaceuticals Inc (CDT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 29.49 | Buy |
| STOCH(9,6) | 9.4666 | Buy |
| STOCHRSI(14) | 24.54 | Neutral |
| MACD(12,26) | -0.0243 | Buy |
| ADX(14) | 15.07 | Neutral |
| William %R | -87.93 | Buy |
| CCI(14) | -178.97 | Sell |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.13
Sell
|
0.1279
Sell
|
| MA20 |
0.13
Sell
|
0.137
Sell
|
| MA50 |
0.1622
Sell
|
0.3359
Sell
|
| MA100 |
1.0273
Sell
|
0.8959
Sell
|
| MA200 |
2.2611
Sell
|
1.7738
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CDT could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CDT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 29.49 indicates that CDT is oversold. This indicates that CDT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 9.4666 indicates that CDT is oversold. This indicates that CDT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.54 indicates that CDT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.07 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -178.97 indicates that CDT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CDT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Conduit Pharmaceuticals Inc financial reports and earnings history, Conduit Pharmaceuticals Inc (CDT) stock could reach $24.96 by 2030, $67.17 by 2040 and $103.43 by 2050. See the projected annual prices until 2050 of the Conduit Pharmaceuticals Inc stock below:
- Conduit Pharmaceuticals Inc (CDT) is expected to reach an average price of $45.00 in 2035, with a high prediction of $46.11 and a low estimate of $45.54. This indicates an $37,872% rise from the last recorded price of $0.1185.
- Conduit Pharmaceuticals Inc (CDT) stock is projected to chart a bullish course in 2040, with an average price target of $64.99, representing an $54,745% surge from its current level. The forecast ranges from a conservative $65.12 to a sky-high $67.17.
- Our analysts predict Conduit Pharmaceuticals Inc (CDT) to jump 69,494% by 2045, soaring from $82.66 to an average price of $82.47, potentially reaching $85.87. While $82.66 is the low estimate, the potential upside is significant.
- Conduit Pharmaceuticals Inc (CDT) stock is expected to climb by 2050, reaching an average of $95.25, a $80,279% jump from its current level. However, a wide range of estimates exists, with high and low targets of $103.43 and $98.22, respectively, highlighting the market's uncertainty.
Conduit Pharmaceuticals Inc Stock (CDT) Year by Year Forecast
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2024
Our forecast for CDT stock price in 2024 now indicates an average price target of $2.8232 with a high forecast of $5.6448 and a low forecast of $0.00159. The average prediction reflects an increase of +2,282% from the last recorded price of $0.1185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $1.4527 | $0.5729 | $1.8527 | +1,126% |
| December, 2024 | $1.4524 | $1.0475 | $2.1176 | +1,126% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2025
Conduit Pharmaceuticals Inc Stock (CDT) is expected to reach an average price of $3.6765 in 2025, with a high prediction of $7.221 and a low estimate of $0.1321. This indicates an +3,003% rise from the last recorded price of $0.1185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.5302 | $1.23 | $2.5397 | +2,879% |
| February, 2025 | $4.0408 | $4.4503 | $4.2506 | +3,310% |
| March, 2025 | $3.6514 | $4.3514 | $4.2826 | +2,981% |
| April, 2025 | $0.2022 | $0.1321 | $2.6979 | +70.65% |
| May, 2025 | $1.8229 | $0.5325 | $0.5929 | +1,438% |
| June, 2025 | $1.5735 | $1.9133 | $1.6333 | +1,228% |
| July, 2025 | $1.0943 | $1.3643 | $1.0339 | +823.45% |
| August, 2025 | $0.2549 | $0.4049 | $0.3152 | +115.13% |
| September, 2025 | $0.1456 | $0.1456 | $0.3344 | +22.84% |
| October, 2025 | $7.5857 | $0.2457 | $6.8657 | +6,301% |
| November, 2025 | $7.2667 | $7.4167 | $7.221 | +6,032% |
| December, 2025 | $2.6829 | $3.5676 | $7.0732 | +2,164% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2026
The predicted value for Conduit Pharmaceuticals Inc (CDT) in 2026 is set at an average of $5.9573. Estimates vary from a peak of $10.19 to a trough of $1.7233, indicating an +4,927% surge from the present price of $0.1185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.1038 | $2.6981 | $2.0038 | +1,675% |
| February, 2026 | $4.1348 | $3.4441 | $3.5548 | +3,389% |
| March, 2026 | $3.4057 | $3.6057 | $3.84 | +2,774% |
| April, 2026 | $2.2419 | $2.4919 | $2.9614 | +1,792% |
| May, 2026 | $1.8829 | $2.0829 | $1.8476 | +1,489% |
| June, 2026 | $6.63 | $1.7233 | $4.59 | +5,495% |
| July, 2026 | $9.8916 | $9.7703 | $10.19 | +8,247% |
| August, 2026 | $9.1429 | $9.8429 | $9.8638 | +7,615% |
| September, 2026 | $5.2444 | $5.2641 | $4.8705 | +4,326% |
| October, 2026 | $6.5057 | $5.3951 | $5.2757 | +5,390% |
| November, 2026 | $5.897 | $6.237 | $6.0467 | +4,876% |
| December, 2026 | $4.9686 | $5.2386 | $5.1777 | +4,093% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Conduit Pharmaceuticals Inc (CDT) is $9.7165, with a high forecast of $16.13 and a low forecast of $3.3011. This indicates an +8,100% increase from the last price of $0.1185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.7699 | $3.9199 | $3.8569 | +3,081% |
| February, 2027 | $3.3011 | $3.3011 | $3.5602 | +2,686% |
| March, 2027 | $13.62 | $3.3114 | $12.90 | +11,390% |
| April, 2027 | $12.94 | $13.09 | $13.16 | +10,818% |
| May, 2027 | $7.7694 | $8.8794 | $12.65 | +6,456% |
| June, 2027 | $6.9664 | $7.8264 | $7.0548 | +5,779% |
| July, 2027 | $8.6379 | $8.2168 | $8.0579 | +7,189% |
| August, 2027 | $7.5495 | $7.7495 | $8.2533 | +6,271% |
| September, 2027 | $5.9365 | $6.1865 | $6.9103 | +4,910% |
| October, 2027 | $5.2181 | $5.4181 | $5.2727 | +4,303% |
| November, 2027 | $12.93 | $4.8443 | $10.89 | +10,811% |
| December, 2027 | $15.74 | $15.98 | $16.13 | +13,185% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2028
In 2028, Conduit Pharmaceuticals Inc (CDT) is projected to reach an average price of $12.74, with a high projection of $19.10 and a low estimate of $6.3772. This indicates an +10,651% rise from the last price of $0.1185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $14.63 | $15.33 | $15.52 | +12,250% |
| February, 2028 | $8.3362 | $10.40 | $10.18 | +6,935% |
| March, 2028 | $11.19 | $10.26 | $9.9586 | +9,342% |
| April, 2028 | $10.22 | $10.56 | $10.46 | +8,525% |
| May, 2028 | $8.8429 | $9.1129 | $9.351 | +7,362% |
| June, 2028 | $7.2848 | $7.4348 | $7.6413 | +6,047% |
| July, 2028 | $6.4567 | $6.4567 | $6.9853 | +5,349% |
| August, 2028 | $19.65 | $6.3772 | $18.93 | +16,479% |
| September, 2028 | $18.61 | $18.76 | $19.10 | +15,604% |
| October, 2028 | $13.08 | $14.19 | $18.24 | +10,939% |
| November, 2028 | $11.83 | $12.69 | $12.28 | +9,882% |
| December, 2028 | $13.14 | $12.99 | $12.65 | +10,990% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2029
The 2029 price forecast for Conduit Pharmaceuticals Inc Stock (CDT) is $14.99 on average, with a high prediction of $22.07 and a low estimate of $7.91. This represents an +12,551% increase from the previous price of $0.1185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.62 | $11.63 | $12.67 | +9,705% |
| February, 2029 | $9.6311 | $9.8811 | $10.87 | +8,028% |
| March, 2029 | $8.5534 | $8.7534 | $8.6978 | +7,118% |
| April, 2029 | $19.23 | $7.91 | $17.19 | +16,128% |
| May, 2029 | $21.59 | $22.13 | $22.07 | +18,122% |
| June, 2029 | $20.13 | $20.83 | $21.19 | +16,884% |
| July, 2029 | $13.47 | $15.53 | $15.49 | +11,266% |
| August, 2029 | $15.87 | $15.12 | $14.64 | +13,294% |
| September, 2029 | $14.54 | $14.88 | $14.94 | +12,173% |
| October, 2029 | $12.72 | $12.99 | $13.58 | +10,632% |
| November, 2029 | $10.80 | $10.95 | $11.43 | +9,014% |
| December, 2029 | $9.6122 | $9.6122 | $10.41 | +8,012% |
Conduit Pharmaceuticals Inc Stock (CDT) Price Forecast for 2030
Conduit Pharmaceuticals Inc Stock (CDT) is expected to reach an average price of $18.73 in 2030, with a high forecast of $28.01 and a low forecast of $9.4429. This signifies an +15,704% surge from the last price of $0.1185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $25.68 | $9.4429 | $24.96 | +21,568% |
| February, 2030 | $24.28 | $24.43 | $25.04 | +20,389% |
| March, 2030 | $18.39 | $19.50 | $23.82 | +15,421% |
| April, 2030 | $17.74 | $17.92 | $17.50 | +14,867% |
| May, 2030 | $17.64 | $17.55 | $17.24 | +14,790% |
| June, 2030 | $15.84 | $16.04 | $17.08 | +13,265% |
| July, 2030 | $13.33 | $13.58 | $14.90 | +11,145% |
| August, 2030 | $11.89 | $12.09 | $12.30 | +9,933% |
| September, 2030 | $25.53 | $10.98 | $23.49 | +21,444% |
| October, 2030 | $27.44 | $27.98 | $28.01 | +23,059% |
| November, 2030 | $25.62 | $26.32 | $26.93 | +21,518% |
| December, 2030 | $18.60 | $20.66 | $20.81 | +15,596% |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):